Key result
Azure XT pacemaker with automatic sensitivity control causes clinically significant P-wave oversensing.
Why the study?
P-wave oversensing is very rare, and clinically significant P-wave oversensing in the Azure XT pacemaker with automatic sensitivity adjustment had not been previously described.
Case Report (n=1)
Highlights a rare but clinically significant risk of P-wave oversensing and ventricular pacing suppression associated with automatic sensitivity adjustment in the Azure XT pacemaker.
Answers are grounded in this paper and cite their sources.
Raises caution for PWOS with automatic-sensitivity pacemakers; hypothesis-generating for sensing algorithm optimization.
Cardiac device sensing has two types: fixed sensitivity and automatic sensitivity. P-wave oversensing (PWOS) is very rare due to the widespread use of fixed sensitivity pacemakers and post-atrial ventricular blanking (PAVB) periods to prevent crosstalk1,2. Azure XT (Medtronic, Minneapolis, MN, USA) employs automatic sensitivity adjustment, and we have previously reported T wave oversensing (TWOS) with Azure XT3. We now report a clinically significant case of PWOS with Azure XT, which, to our knowledge, has not been previously described in this device.
No takes yet. Share an insight, caveat, or question.
Sasaki et al. (2026) conducted a case report in P-wave oversensing (n=1). Azure XT pacemaker was evaluated on P-wave oversensing. A clinically significant case of P-wave oversensing was observed with the Azure XT pacemaker, a device employing automatic sensitivity adjustment.
Synapse has enriched 10 related papers. Consider them for comparative context: